HMOX1 and Miyoshi myopathy: In conclusion, the present study demonstrates that treatment of MM cells with BTZ results in a cross-regulation between TLR4 and HO-1/CO signaling pathways, thus serving as a stress-responsive mechanism to increase UPR response and finally protecting mitochondria against the cytotoxic effects of BTZ and thus promoting drug resistance.